Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Nonmyeloablative regimens for allogeneic hematopoietic cell transplantation (HCT) have been developed for patients ineligible for myeloablative conditioning. We compared regimen-related toxicities (RRTs) and nonrelapse mortality (NRM) in 73 nonmyeloablative and 73 myeloablative recipients of HLA-matched related donor HCT, using the National Cancer Institute (NCI) Common Toxicity Criteria. Nonmyeloablative regimens were 2 Gy total body irradiation (TBI), either alone (n = 40) or combined with fludarabine, 30 mg/m2/d for 3 days (n = 33). Posttransplantation immunosuppression included mycophenolate mofetil and cyclosporine. Myeloablative regimens consisted mostly of cyclophosphamide + TBI or busulfan + cyclophosphamide, followed by posttransplantation methotrexate and cyclosporine. Nonmyeloablative patients were at higher risk than ablative patients because of greater age, longer time from diagnosis to HCT, more frequent preceding high-dose HCT, and higher pretransplantation Charlson comorbidity scores. Nevertheless, they experienced significantly less severe toxicities in 7 organs/systems: hematologic, gastrointestinal, hepatic, hemorrhage, infection, metabolic, and pulmonary. This translated into less NRM at day 100 (3% versus 23%, P = 10-4) and 1 year (16% versus 30%, P = .04). In multivariate analysis, the strongest factor predicting lessened RRT and NRM was nonmyeloablative conditioning, whereas high pretransplantation comorbidity scores predicted higher NRM. In conclusion, nonmyeloablative regimens had lower RRT and NRM and could be considered for comparative studies, including younger patients with more favorable Charlson comorbidity scores.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 1×
“Time to transplantation, mo (range) 22 (2-159) 12 (1-198) .”
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
1994 Consensus Conference on Acute GVHD Grading.
Przepiorka, D., Weisdorf, D., Martin, P., Hg, K., Beatty, P., Hows, J., & Thomas, E. D. (1995) · PubMed · Cited by 5,037
Statistical Models Based on Counting Processes
Bry, X., Andersen, P. K., Borgan, Ø., Gill, R. D., Keiding, N., & Borgan, O. (1997) · Population (French Edition) · doi:10.2307/1534625 · Cited by 2,884
Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., et al. (1998) · Blood · doi:10.1182/blood.v91.3.756 · Cited by 2,071
Storb, R., Deeg, H. J., Whitehead, J., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C. D., Clift, R., Doney, K., Farewell, V., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411
Self-citationMcSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,389
Self-citationMcDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Childs, R., Chernoff, A., Contentin, N., Bahceci, E., Schrump, D., Leitman, S., Read, E. J., Tisdale, J., Dunbar, C., Linehan, W. M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009143431101 · Cited by 998
Bensinger, W. I., Martin, P. J., Storer, B., Clift, R., Forman, S. J., Negrin, R., Kashyap, A., Flowers, M. E. D., Lilleby, K., Chauncey, T. R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101183440303 · Cited by 962
Self-citationRegimen-related toxicity in patients undergoing bone marrow transplantation.
Bearman, S. I., Appelbaum, F. R., Buckner, C. D., Petersen, F. B., Fisher, L. D., Clift, R. A., & Thomas, E. D. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.10.1562 · Cited by 868
Chronic graft-versus-host disease and other late complications of bone marrow transplantation.
Sullivan, K. M., Agura, E. D., Anasetti, C., Appelbaum, F. R., Badger, C. C., Bearman, S. I., Erickson, K., Flowers, M. E. D., Hansen, J. A., & Loughran, T. P. (1991) · PubMed · Cited by 790
Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)
DeLeve, L. D., Shulman, H. M., & McDonald, G. B. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-23204 · Cited by 664
Hematopoietic Cell Transplantation
Forman, S. J., & Nakamura, R. (2015) · Blackwell Science Ltd eBooks · Cited by 659
Clift, R., Buckner, C., Appelbaum, F., Bearman, S., Petersen, F., Fisher, L., Anasetti, C., Beatty, P., Bensinger, W., & Doney, K. (1990) · Blood · doi:10.1182/blood.v76.9.1867.1867 · Cited by 585
Mielcarek, M., Martin, P. J., Leisenring, W., Flowers, M. E. D., Maloney, D. G., Sandmaier, B. M., Maris, M. B., & Storb, R. (2003) · Blood · doi:10.1182/blood-2002-08-2628 · Cited by 562
Self-citationBone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen
Tutschka, P., Copelan, E., & Klein, J. (1987) · Blood · doi:10.1182/blood.v70.5.1382.1382 · Cited by 541
Childs, R., Clave, E., Contentin, N., Jayasekera, D., Hensel, N., Leitman, S., Read, E. J., Carter, C., Bahceci, E., Young, N. S., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3234 · Cited by 526
Giralt, S., Thall, P. F., Khouri, I., Wang, X., Braunschweig, I., Ippolitti, C., Claxton, D., Donato, M., Bruton, J., Cohen, A., et al. (2001) · Blood · doi:10.1182/blood.v97.3.631.h8000631_631_637 · Cited by 514
Marr, K. A., Seidel, K., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 511
Kottaridis, P. D., Milligan, D. W., Chopra, R., Chakraverty, R. K., Chakrabarti, S., Robinson, S., Peggs, K., Verfuerth, S., Pettengell, R., Marsh, J. C. W., et al. (2000) · Blood · doi:10.1182/blood.v96.7.2419 · Cited by 504
Maloney, D. G., Molina, A. J., Sahebi, F., Stockerl-Goldstein, K. E., Sandmaier, B. M., Bensinger, W., Storer, B., Hegenbart, U., Somlo, G., Chauncey, T., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2955 · Cited by 403
Self-citationAllogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome
Bensinger, W., Buckner, C., Anasetti, C., Clift, R., Storb, R., Barnett, T., Chauncey, T., Shulman, H., & Appelbaum, F. (1996) · Blood · doi:10.1182/blood.v88.7.2787.bloodjournal8872787 · Cited by 316
Self-citationDeeg, H. J., Storer, B., Slattery, J. T., Anasetti, C., Doney, K. C., Hansen, J. A., Kiem, H.-P., Martin, P. J., Petersdorf, E., Radich, J. P., et al. (2002) · Blood · doi:10.1182/blood-2002-02-0527 · Cited by 284
Self-citationJunghanss, C., Marr, K. A., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Chauncey, T., McSweeney, P. A., & Storb, R. (2002) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2002.v8.pm12374456 · Cited by 251
Self-citationSpitzer, T. R., McAfee, S., Sackstein, R., Colby, C., Toh, H. C., Multani, P., Saidman, S., Weymouth, D., Preffer, F., Poliquin, C., et al. (2000) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(00)70056-5 · Cited by 247
Junghanss, C., Boeckh, M., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Chauncey, T., McSweeney, P. A., Little, M.-T., Corey, L., et al. (2002) · Blood · doi:10.1182/blood.v99.6.1978 · Cited by 241
Self-citationBearman, S. I., Lee, J. L., Barón, A. E., & McDonald, G. B. (1997) · Blood · doi:10.1182/blood.v89.5.1501 · Cited by 189
Badros, A. Z., Barlogie, B., Siegel, E., Cottler-Fox, M., Zangari, M., Fassas, A., Morris, C., Anaissie, E., Rhee, F. V., & Tricot, G. J. K. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1295 · Cited by 186
Schots, R., Kaufman, L., Van Riet, I., Ben Othman, T., De Waele, M., Van Camp, B., & Demanet, C. (2003) · Leukemia · doi:10.1038/sj.leu.2402946 · Cited by 170
Sullivan, K. M., Dykewicz, C. A., Longworth, D. L., Boeckh, M., Baden, L. R., Rubin, R. H., & Sepkowitz, K. A. (2001) · Hematology · doi:10.1182/asheducation-2001.1.392 · Cited by 166
Hogan, W. J., Maris, M., Storer, B., Sandmaier, B. M., Maloney, D. G., Schoch, H. G., Woolfrey, A. E., Shulman, H. M., Storb, R., & McDonald, G. B. (2004) · Blood · doi:10.1182/blood-2003-04-1311 · Cited by 157
Self-citationAttal, M., Huguet, F., Rubie, H., Charlet, J.-P., Schlaifer, D., Huynh, A., Laurent, G., & Pris, J. (1993) · Blood · doi:10.1182/blood.v82.3.732.732 · Cited by 112
Use of Dapsone in the Prevention and Treatment ofPneumocystis cariniiPneumonia: A Review
Hughes, W. T. (1998) · Clinical Infectious Diseases · doi:10.1086/514626 · Cited by 111
Ra, C., Bianco, J., Appelbaum, F. R., Buckner, C. D., Singer, J. W., Bakke, L., Singer, J. W., Bowden, R., McDonald, G., & Schubert, M. (1993) · Blood · doi:10.1182/blood.v82.7.2025.2025 · Cited by 104
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning
Maris, M. B., Boeckh, M., Storer, B. E., Dawson, M. A., White, K., Keng, M. K., Sandmaier, B. M., Maloney, D. G., Storb, R. F., & Storek, J. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00201-7 · Cited by 98
Self-citationFeinstein, L. C., Sandmaier, B. M., Hegenbart, U., McSweeney, P. A., Maloney, D. G., Gooley, T. A., Maris, M. B., Chauncey, T. R., Bruno, B., Appelbaum, F. R., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04057.x · Cited by 93
Self-citationEssell, J., Thompson, J., Harman, G., Halvorson, R., Snyder, M., Johnson, R., & Rubinsak, J. (1992) · Blood · doi:10.1182/blood.v79.10.2784.2784 · Cited by 76
Demirer, T., Petersen, F. B., Appelbaum, F. R., Barnett, T., Sanders, J. E., Deeg, H. J., Storb, R. F., Doney, K., Bensinger, W., Shannon‐Dorcy, K., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00115-f · Cited by 40
Self-citationHandbook of Bone Marrow Transplantation
Carella, A. M., Lazarus, H. M., & Rowe, J. M. (2000) · Medical Entomology and Zoology · Cited by 21
Sandmaier, B., Maloney, D. G., Gooley, T. A., Shizuru, J. A., Hegenbart, U., Sahebi, F., Chauncey, T. R., Bruno, B., Agura, E. D., McSweeney, et al. (2002) · Cited by 14
Self-citation
Cited by
Sorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B. (2005) · Blood · doi:10.1182/blood-2005-05-2004 · Cited by 2,969
Self-citationFerrara, J. L., Levine, J. E., Reddy, P., & Holler, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60237-3 · Cited by 2,464
Drug therapy for acute myeloid leukemia
Tallman, M. S., Gilliland, D. G., & Rowe, J. M. (2005) · Blood · doi:10.1182/blood-2005-01-0178 · Cited by 661
Upton, A., Kirby, K. A., Carpenter, P., Boeckh, M., & Marr, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510592 · Cited by 514
Aoudjhane, M., Labopin, M., Gorin, N. C., Shimoni, A., Ruutu, T., Kolb, H.-J., Frassoni, F., Boiron, J. M., Yin, J. L., Finke, J., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403967 · Cited by 459
Metadata
- Authors
- Diaconescu, R., Flowers, C. R., Storer, B., Sorror, M. L., Maris, M. B., Maloney, D. G., Sandmaier, B. M., & Storb, R.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-09-01
- Volume
- 104
- Issue
- 5
- Pages
- 1550-1558
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2087380692
- Cited by
- 322
- References
- 42
- FWCI
- 23.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.